Filing Details
- Accession Number:
- 0001628945-22-000192
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-09 20:32:18
- Reporting Period:
- 2022-12-08
- Accepted Time:
- 2022-12-09 20:32:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1628945 | Cue Health Inc. | HLTH | Laboratory Analytical Instruments (3826) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1868945 | Clint Sever | C/O Cue Health Inc. 4980 Carroll Canyon Rd. Suite 100 San Diego CA 92121 | Chief Product Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-08 | 29,269 | $0.20 | 3,968,916 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-12-08 | 29,269 | $3.02 | 3,939,647 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2022-12-08 | 29,269 | $0.00 | 29,269 | $0.20 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-12-31 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were automatically effected pursuant to a rule 10b5-1 trading plan adopted on June 6, 2022 and established by the reporting person for the purpose of an orderly sale of shares related to the exercises of options scheduled to expire on December 31, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $3.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- Shares subject to the option are fully vested and immediately exercisable.